http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7ab8f635b13d2db78cc742027f0fe97
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hedley |
| name | David Hedley |
| given-name | David |
| organization-name | Ontario Cancer Institute/Princess Margaret Cancer Centre Toronto Ontario Canada Ontario Cancer Institute/Princess Margaret Hospital Toronto ON M5G 2M9 Canada; Division of Medical Oncology and Hematology Princess Margaret Hospital Toronto ON M5G 2M9 Canada 1Wallace McCain Centre for Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada. From Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Centre for Medical Psychology and Evidence-Based Decision-Making, University of Sydney; Concord Repatriation General Hospital and Royal Prince Alfred Hospital, Sydney Cancer Centre; Westmead Hospital; and Prince of Wales Hospital, Sydney, Australia. Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada 1Princess Margaret Phase II Consortium, Toronto, Canada, and Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada Division of Medical Oncology and Hematology Princess Margaret Cancer Centre 610 University Avenue Toronto ON M5G 2 M9 Canada From the Department of Medical Oncology & Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada 1Divisions of Applied Molecular Oncology,; 3Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Spring Holter, Ayelet Borgida, Robert Grant, Kara Semotiuk, and Steven Gallinger, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital; Anna Dodd, David Hedley, Neesha Dhani, Malcolm Moore, and Steven Gallinger, McCain Pancreatic Cancer Centre, University Health Network; and Steven Narod and Mohammad Akbari, Women's College Research Institute, Toronto, Ontario, Canada. Department of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada Division of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, Toronto Ontario Canada Division of Experimental Therapeutics and Department of Radiation Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada. david.hedley@ubn.on.ca Ontario Cancer Institute/Princess Margaret Cancer Center, Toronto, Ontario, Canada Ontario Cancer Institute and Princess Margaret Hospital Toronto Ontario, Canada From the Departments of Biostatistics and Medical Oncology, Radiation Medicine Program, and the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network; Department of Laboratory Medicine, St Michael's Hospital; Dalla Lana School of Public Health and the Departments of Laboratory Medicine and Pathobiology, Medicine, University of Toronto; Department of Radiation Oncology, University of Toronto, Toronto, Canada. From the Princess Margaret Hospital Phase II Consortium; Ontario Cancer Institute, Toronto; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Vanderbilt University Medical Center, Nashville, TN; and the National Cancer Institute, Bethesda, MD Divsion of Medical Oncology and Hematology Princess Margaret Hospital Toronto Ontario Canada Departments of Radiation Oncology, Medical Biophysics, and the STTARR Innovaton Centre Princess Margaret Cancer Centre University Health Network 101 College Street Toronto Ontario M5G 1L7 Canada From the Departments of Hematology, Medical Oncology, and Biostatistics, Princess Margaret Hospital/University Health Network; and Department of Medicine, University of Toronto 1Ontario Cancer Institute/Princess Margaret Hospital,; 5Medicine,; 6Pathology, and Divsion of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre Toronto Ontario Canada |
Incoming Links
Total number of triples: 151.